Ongoing research examines COVID‐19 vaccination effectiveness in patients with cancer and survivors

Researchers at The Ohio State University Comprehensive Cancer Center (OSUCCC-James) are gathering information on the impact of the SARS-CoV-2 virus on, and the efficacy of COVID-19 vaccines in, immunocompromised patients with cancer and cancer survivors. “While we are not seeing these patients coming for medical care with breakthrough COVID-19 infections, there are many questions about the prevalence of asymptomatic infections, how long immunity...